Table 1.
Clinicopathological characteristics
| Number | Percentage | ||
|---|---|---|---|
| Cases |
|
|
|
| |
Normal |
11 |
|
| |
Cancer |
45 |
|
| Grade |
|
|
|
| |
I |
11 |
24% |
| |
II |
14 |
31% |
| |
III |
20 |
45% |
| Estrogen receptor |
|
|
|
| |
Positive |
20 |
44% |
| |
Negative |
25 |
56% |
| Progesterone receptor |
|
|
|
| |
Positive |
19 |
42% |
| |
Negative |
26 |
58% |
| HEr2/Neu |
|
|
|
| |
Positive |
21 |
47% |
| |
Negative |
24 |
53% |
| Age |
|
|
|
| |
≤45 |
9 |
20% |
| |
>45 |
36 |
80% |
| T Classification |
|
|
|
| |
T1 |
16 |
36% |
| |
T2 |
19 |
42% |
| |
T3 |
8 |
18% |
| |
T4 |
2 |
4% |
| N Classification |
|
|
|
| |
N0 |
21 |
47% |
| |
N1 |
16 |
36% |
| |
N2 |
5 |
11% |
| N3 | 3 | 6% |